WFDC2 and cancer: Although there are a number of systematic reviews and meta-analysis studies highlighting the value of HE4 as a prognostic and diagnostic marker in EOC, a comprehensive study that takes into consideration, HE4's multiple use cases and its potential as a biomarker in other relevant cancer types (EOC, lung, and endometrial) has not been performed.